PARMOL 250 SUSPENSION 250 mg/5 ml
Product details
Registration number: SIN05565P
Classification: General Sale List
Active ingredients: PARACETAMOL
Strength: 250 mg/5 ml
Dosage form: SUSPENSION
Route: ORAL
Registrant: GOLDPLUS UNIVERSAL PTE LTD
ATC code: N02BE01
HSA approval date: 20 March 1991
Manufacturer(s): HOVID BHD
Manufacturing country/countries: MALAYSIA
What are the HSA registration number and classification for PARMOL 250 SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN05565P
Classification: General Sale List
What active ingredients and strength are recorded for PARMOL 250 SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: PARACETAMOL
Strength: 250 mg/5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PARMOL 250 SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: SUSPENSION
Route: ORAL
Who is the recorded registrant for PARMOL 250 SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Which manufacturers and countries are listed for PARMOL 250 SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): HOVID BHD
Manufacturing country/countries: MALAYSIA
Where can I look up PARMOL 250 SUSPENSION 250 mg/5 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN05565P or the exact product name PARMOL 250 SUSPENSION 250 mg/5 ml. The general register link does not preselect this product.
What are the source dates for this PARMOL 250 SUSPENSION 250 mg/5 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PARMOL 250 SUSPENSION 250 mg/5 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN05565P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)